Rheumatology

The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.

MEDICAL FRONTIERS - 12th Annual European Congress of Rheumatology (EULAR)

Preventing Rheumatoid Arthritis Progression: A Recent Demonstration of the Efficacy of Biologics

London, UK / May 25-28, 2011

London - Relative to disease-modifying antirheumatic drugs (DMARDs), the targeted biologic agents have demonstrated remarkable efficacy, often achieving full restoration of function in patients with refractory and disabling symptoms. It has...

PRIORITY PRESS - 12th Annual European Congress of Rheumatology (EULAR)

Success of Biologics in Rheumatoid Arthritis: From Efficacy of IL-6 Inhibition to Validation of Targeting New Inflammatory Pathways

London, UK / May 25-28, 2011

London - Current biologics, which include tumour necrosis factor (TNF) and interleukin-6 (IL-6) receptor inhibitors, act by exerting control over key molecular steps in the inflammatory process of rheumatoid arthritis (RA). Their ability to...

PRIORITY PRESS - 12th Annual European Congress of Rheumatology (EULAR)

New Treatment Option for Gout-related Hyperuricemia

London, UK / May 25-28, 2011

Until recently, treatment of gout involved either enhancement of renal uric acid excretion with a uricosuric, such as probenecid, or inhibition of urate production with the purine-based analogue allopurinol, a xanthine oxidase inhibitor....

PRIORITY PRESS - 12th Annual European Congress of Rheumatology (EULAR)

Insights Into Tight Rheumatoid Arthritis Control and Treating-to-Target Approaches

London, UK / May 25-28, 2011

London - Experts at this year’s EULAR agreed that rapid control of inflammation is essential in rheumatoid arthritis (RA). In 2010, the EULAR guidelines were revised to define the treatment goal as an absence of signs and symptoms as well...

JOURNAL CLUB - Rheumatology

Tight Disease Control and Treating to Target in Rheumatoid Arthritis: An International Task Force Perspective

December 2010

Based on Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 2010;69(4):631-7 and Presentations from the 2010 Annual European Congress of Rheumatology (EULAR) Rome, Italy / June 16-19,...

MEDICAL FRONTIERS - 61st Annual Refresher Course for Family Physicians

Disease Prevention in Primary Care

McGill University, Montreal, Quebec / November 28-December 1, 2010

Which Lifestyle Changes Are Effective? Lifestyle measures can promote overall health, prevent disease and extend life. In patients already taking antihypertensive or lipid-lowering therapy, lifestyle modification may be more effective than...

PRIORITY PRESS - 74th Annual Meeting of the American College of Rheumatology and the 45th Annual Meeting of the Association of Rheumatology Health Professionals

Evolving Management of Extra-articular Rheumatic Disease

Atlanta, Georgia / November 7-11, 2010

Atlanta - It is estimated that 30% of patients with psoriasis also have psoriatic arthritis (PsA), a potential cause for irreversible joint damage. Many tools have been developed in order to identify active PsA earlier among individuals...

MEDICAL FRONTIERS - 74th Annual Meeting of the American College of Rheumatology

Selective B-cell-Targeted Therapy in Rheumatoid Arthritis and Other Autoimmune Diseases

Atlanta, Georgia / November 7-11, 2010

Atlanta - Treatment of rheumatoid arthritis (RA) with biologics has led to a fundamental shift in therapy. While tumour necrosis factor (TNF) inhibitors are used as first-line biologics, 30% of patients treated do not sufficiently respond...

PRIORITY PRESS - 32nd Annual Meeting of the American Society for Bone and Mineral Research (ASBMR)

Preserving Bone and Muscle Health

Toronto, Ontario / October 15-19, 2010

TO EARN CME CREDITS, PLEASE SEE BELOW Toronto - With our aging population, the incidence of age-related diseases, including osteoporosis (OP), is increasing. Age-related muscle loss is also common and strategies aimed at preventing falls...

PHYSICIAN PERSPECTIVE - Viewpoint Based on presentations from 32nd Annual Meeting of the American Society for Bone and Mineral Research (ASBMR)

Highlights from ASBMR 2010

Toronto, Ontario / October 15-19, 2010

INTRODUCTION With the aging populations in Western countries, the frequency of diseases associated with aging, including osteoporosis (OP), will become an increasing burden. Age-related bone and muscle loss are common and therefore...

PAGE 3 OF 7   1 2 3 4 5 6 7